Yan Xu

2.5k citations
87 papers · 1.7k indexed · h-index 24
Topics
Monoclonal and Polyclonal Antibodies Research (9 papers)Biosimilars and Bioanalytical Methods (7 papers)Mitochondrial Function and Pathology (5 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yan Xu

84 papers receiving 1.7k citations

Peers

Yan Xu
Comparison fields: 5 of 117
  • Molecular Biology 796
  • Cancer Research 222
  • Inorganic Chemistry 200
  • Epidemiology 176
  • Materials Chemistry 172
Replace Hongguang Xia with:
Hongguang Xia China
César Echeverría Chile
Artak Tovmasyan United States
Concettina La Motta Italy
Montserrat Miralpeix Spain
Eun Joo Roh South Korea
Fengtian Xue United States
Sumit Sahni Australia
Limei Yan China
William Leister United States
Yan Xu relative to Hongguang Xia China Hongguang Xia's profile →
Citations per field
00.5×3.4×
Hongguang Xia · 1×
Citations per year

Countries citing papers authored by Yan Xu

Since Specialization
Citations

This map shows the geographic impact of Yan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xu more than expected).

Fields of papers citing papers by Yan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xu. The network helps show where Yan Xu may publish in the future.

Co-authorship network of co-authors of Yan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Xu. A scholar is included among the top collaborators of Yan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Xu. Yan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 23
5 4
6 3
7 5
8 24
9 20
10 8
11 0
12 12
13 5
14 1
15
Efficacy and safety of combined etanercept and iguratimod for active rheumatoid arthritis
2
16 170
17 95
18 6
19 21
20 43

About Yan Xu

Yan Xu is a scholar working on Horticulture, Immunology and Neurology, having authored 87 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Biosimilars and Bioanalytical Methods (7 papers) and Mitochondrial Function and Pathology (5 papers). The work is most often cited by research in Cancer Research (222 citations), Inorganic Chemistry (200 citations) and Molecular Biology (796 citations). Yan Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianjiang Lu, Ronald S. Kaplan, June A. Mayor, Lian Sai Chia, David A. Gremse, Ricky Y.K. Man, Jingjing Cheng, Xibao Yu, Shaohua Chen and Susan W.S. Leung. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026